Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-06-02 | Genovis | Genovis AB: Genovis launch Innovative IgM-Specific Protease with Wide-Ranging Applications in Life Science Markets | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-02 | Genovis | Genovis AB: Genovis lanserar unikt IgM-specifikt enzym med breda tillämpningar inom Life Science-marknaden | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-17 | Redeye | Redeye: Genovis Q1 2023 - Strongest report to date | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-16 | Genovis | Communiqué from Genovis AB (publ) Annual General Meeting May 16, 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-16 | Genovis | Kommuniké från Årsstämman i Genovis AB (publ) den 16 maj 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-16 | Genovis | Genovis AB: Interim Report January-March 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-16 | Genovis | Genovis AB: Kvartalsrapport januari-mars 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-03 | Genovis | Genovis AB: Genovis and ArcticZymes Technologies enter into a collaboration agreement to accelerate growth in China | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-03 | Genovis | Genovis AB: Genovis och ArcticZymes Technologies ingår samarbetsavtal för att accelerera tillväxt på den kinesiska marknaden | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-25 | Genovis | Genovis AB: Genovis acquires IP Rights to novel enzymes for applications within genomics | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Genovis AB: Genovis acquires IP Rights to novel enzymes for applications within genomicsAs a leading developer of enzymes for the life science industry, Genovis has acquired the rights to a new enzyme developed by researchers at Uppsala University, led by Professor Ola Söderberg. ”We have developed a new type of DNA polymerase with properties that could not have arisen naturally. This laboratory-created DNA polymerase opens up fantastic opportunities for biotechnology and medical research”, says Ola Söderberg The acquisition of the rights gives Genovis exclusive rights to develop and commercialize products based on the DNA polymerase. With the acquisition of the IP rights, Genovis will expand its customer offering to include enzymes in genomics. ”We are excited to have the opportunity to acquire the rights to a unique enzyme with potential uses in several applications within the life science field, from research to diagnostics and forensics. The acquisition follows our strategy to commercialize academic research into high-value products and broaden our offerings”, says Fredrik Olsson, CEO of Genovis. In preparation for the commercialization of the enzyme, Genovis will initiate collaborations with partners as part of the continued product development. |
||||
2023-04-25 | Genovis | Genovis AB: Genovis förvärvar patenträttigheter till nytt enzym inom genomics | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-25 | Genovis | Genovis AB: Genovis årsredovisning 2022 publicerad | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-25 | Genovis | Genovis AB: Genovis Annual Report 2022 published | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-11 | Genovis | Genovis AB: NOTICE CONVENING THE 2023 ANNUAL GENERAL MEETING | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-11 | Genovis | Genovis AB: KALLELSE TILL ÅRSSTÄMMA 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-16 | Redeye | Redeye: Genovis Q4 2022 - A First Sublicensing of Xork | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-15 | Genovis | Genovis AB: Year-end Report January-December 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-02-15 | Genovis | Genovis AB: Bokslutskommuniké januari-december 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-01-09 | Genovis | Genovis AB: Genovis erhåller direkt 4 MUSD efter att Selecta Biosciences sub-licensierat Xork™-enzymet till Astellas Pharma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-09 | Genovis | Genovis AB: Genovis to receive 4 MUSD upfront after Selecta Biosciences sublicensed Xork™ enzyme to Astellas Pharma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-12-12 | Redeye | Redeye: Genovis - Bull Story, Fair Price | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-15 | Genovis | Genovis AB: Interim Report January-September 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-11-15 | Genovis | Genovis AB: Delårsrapport januari-september 2022 | Rapporter | Ladda ner | Visa Stäng |
|